• Medientyp: E-Artikel
  • Titel: Use of Recombinant Mitogillin for Improved Serodiagnosis ofAspergillus fumigatus-Associated Diseases
  • Beteiligte: Weig, Michael; Frosch, Matthias; Tintelnot, Kathrin; Haas, Andrea; Groß, Uwe; Linsmeier, Bernd; Heesemann, Jürgen
  • Erschienen: American Society for Microbiology, 2001
  • Erschienen in: Journal of Clinical Microbiology
  • Sprache: Englisch
  • DOI: 10.1128/jcm.39.5.1721-1730.2001
  • ISSN: 0095-1137; 1098-660X
  • Schlagwörter: Microbiology (medical)
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>ABSTRACT</jats:title><jats:p>During human infection,<jats:italic>Aspergillus fumigatus</jats:italic>secretes a 18-kDa protein that can be detected as an immunodominant antigen in the urine of infected patients. Recently, this protein was shown to be mitogillin, a ribotoxin that cleaves a single phosphodiester bond of the 29S rRNA of eukaryotic ribosomes. We proved the immunogenic capacity of mitogillin in a rabbit animal model, indicating its usefulness as an antigen for serological diagnosis of invasive aspergillosis. The mitogillin gene from<jats:italic>A. fumigatus</jats:italic>was transferred from plasmid pMIT+ to expression vector pQE30 and expressed in<jats:italic>Escherichia coli</jats:italic>as a fusion protein. Purified recombinant mitogillin was recognized by serum immunoglobulin G (IgG) of polyclonal rabbit sera that were obtained by immunization with purified native mitogillin. Consequently, we developed an enzyme-linked immunosorbent assay for detection of IgG, IgM, and IgA antibodies to recombinant mitogillin. In serum samples of patients suffering from aspergilloma (AO;<jats:italic>n</jats:italic>= 32), invasive pulmonary aspergillosis (IPA;<jats:italic>n</jats:italic>= 42), or invasive disseminated aspergillosis (IDA;<jats:italic>n</jats:italic>= 40), a good correlation of production of IgG antibody against mitogillin and clinical disease was observed (for patients with AO, 100% [32 of 32] were positive; for patients with IPA, 64% [31 of 42] were positive; for patients with IDA, 60% [24 of 40] were positive). In contrast, positive titers for serum IgG and IgM antibodies against mitogillin were found in only 1.3% of the serum samples of healthy volunteers and positive titers for IgA antibody were found in only 1.0% of the serum samples of healthy volunteers (<jats:italic>n</jats:italic>= 307; specificity = 95.4%). These results indicate that recombinant mitogillin expressed in<jats:italic>E. coli</jats:italic>can be used for improvement of the serodiagnosis of<jats:italic>A. fumigatus</jats:italic>-associated diseases.</jats:p>
  • Zugangsstatus: Freier Zugang